Engineering His-Tagged Senecavirus A for One-Step Purification of Viral Antigens
Overview
Authors
Affiliations
Senecavirus A (SVA) is a picornavirus that causes vesicular disease in swine, and the inactivated vaccine is used to prevent and control SVA infection. To develop a new chromatography strategy for the purification and concentration of SVA vaccine antigens, we inserted a 6×His-tag at the VP1 C-terminal of the SVA/HLJ/CHA/2016 in an infectious clone to rescue a His-tagged SVA. The constructed and rescued recombinant virus, named as rSVA-His, exhibited similar growth kinetics to that of its parental virus. In addition, the expression of a 6×His-tag on the surface of SVA showed genetic stability in cell passages in vitro, which allowed one-step purification of SVA antigens by Ni affinity columns. Furthermore, the immunogenicity of the inactivated rSVA-His was evaluated by inoculating rabbits and detecting neutralizing antibodies. The animals receiving two doses of the inactivated rSVA-His emulsified with oil adjuvant developed a high titer of neutralizing antibodies, indicating that SVA VP1 is tolerant to His-tag insertion without detriment to its antigenicity. In summary, the constructed 6×His-tagged SVA may offer a feasible approach to the affinity purification and concentration of antigens in the process of SVA inactivated vaccine production.
Khan M, Shakya M, Verma C Mol Divers. 2025; .
PMID: 40057939 DOI: 10.1007/s11030-025-11148-z.
Applying Reverse Genetics to Study Measles Virus Interactions with the Host.
Vera-Peralta H, Najburg V, Combredet C, Douche T, Giai Gianetto Q, Matondo M Methods Mol Biol. 2024; 2808:89-103.
PMID: 38743364 DOI: 10.1007/978-1-0716-3870-5_7.
Elshafei S, Mahmoud N, Almofti Y Sci Rep. 2024; 14(1):2870.
PMID: 38311642 PMC: 10838928. DOI: 10.1038/s41598-024-53048-6.
Palatnik-de-Sousa I, Wallace Z, Cavalcante S, Ribeiro M, Silva J, Cavalcante R Sci Rep. 2022; 12(1):16731.
PMID: 36202985 PMC: 9537284. DOI: 10.1038/s41598-022-21207-2.
Liu W, Li X, Zhang H, Hao G, Shang X, Wang H Vaccines (Basel). 2022; 10(4).
PMID: 35455380 PMC: 9032702. DOI: 10.3390/vaccines10040631.